3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Keratosis, Actinic
12
Warts
11
Breast Neoplasms
11
Uterine Cervical Dysplasia
7
Retinoblastoma
6
Prostatic Neoplasms
6
Peripheral Nervous System Diseases
6
Pain
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Neoplasms
5
Stomatitis
4
Pancreatic Neoplasms
3
Mucositis
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Multiple Myeloma
2
Mesothelioma
2
Melanoma
2
Keratosis
2
Condylomata Acuminata
2
Carcinoma, Ductal, Breast
2
Carcinoma, Basal Cell
2
Bone Neoplasms
2
Barrett Esophagus
2
Adenocarcinoma Of Esophagus
2
Wilms Tumor
1
Interventions
Diathermy
20
Radiotherapy
10
Cisplatin
5
Fluorouracil
4
Drug Therapy
4
Radiation
3
Melphalan
3
Immune Checkpoint Inhibitors
3
Cytoreduction Surgical Procedures
3
Brachytherapy
3
tislelizumab
2
Solutions
2
Immunotherapy
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Doxorubicin
2
Conization
2
Capecitabine
2
spartalizumab
1
sodium thiosulfate
1
anlotinib
1
Temozolomide
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Leucovorin
1
Laser Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hyperthermia
×
Cryotherapy
×
Clear all
NCT04778631
2025-11-20
PERISAFE
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
115 enrolled